A single Swiss man’s semen sample is now headline news on three continents. What’s behind the hysteria? A Gates-funded journalism desk, a biosurveillance firm backed by the CIA’s venture capital arm, and a Swiss biodefense laboratory. And they’re all feeding each other a story that the underlying science doesn’t support.